Ellagic acid regulates hyperglycemic state through modulation of pancreatic IL-6 and TNF- α immunoexpression

BACKGROUND: Type 2 diabetes (T2DM) is a chronic metabolic disorder. Although therapeutic pharmaceutical agents continue to advance, herbal medicines are potential complementary treatments for the promotion of glucose homeostasis, with minimal adverse effects. Conventionally, ellagic acid (EA) has be...

Descripción completa

Detalles Bibliográficos
Autores principales: Elbandrawy, Manal M., Sweef, Osama, Elgamal, Doaa, Mohamed, Tarek M., EhabTousson, Elgharabawy, Rehab M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280239/
https://www.ncbi.nlm.nih.gov/pubmed/35844391
http://dx.doi.org/10.1016/j.sjbs.2022.03.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280239/
https://www.ncbi.nlm.nih.gov/pubmed/35844391
http://dx.doi.org/10.1016/j.sjbs.2022.03.016

Ejemplares similares